NATIONAL HEART CENTRE SINGAPORE
- Country
- 🇸🇬Singapore
- Ownership
- -
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.nhcs.com.sg/
Clinical Trials
60
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)
- Conditions
- Valve Disease, Heart
- First Posted Date
- 2025-07-10
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- National Heart Centre Singapore
- Target Recruit Count
- 150
- Registration Number
- NCT07058935
- Locations
- 🇦🇺
John Hunter Hospital, New Lambton Heights, Australia
🇭🇰Prince of Wales Hospital, Hong Kong, Hong Kong
🇭🇰Queen Elizabeth Hospital, Hong Kong, Hong Kong
Using Laser Spatiotemporal Photoplethysmogram and Computational Method for Management of Chronic Disorders.
- Conditions
- Blood Glucose MonitoringBlood Pressure Measurement
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- National Heart Centre Singapore
- Target Recruit Count
- 200
- Registration Number
- NCT06717646
- Locations
- 🇸🇬
National Heart Centre Singapore, Singapore, Singapore
UNdeRstAnding Novel Variants in AcutE MyocardiaL Infarction in Young Adults
- Conditions
- Myocardial Infarction, Acute
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- National Heart Centre Singapore
- Target Recruit Count
- 1200
- Registration Number
- NCT06698341
- Locations
- 🇸🇬
National Heart Centre Singapore, Singapore, Singapore
Comparison of the Diagnostic Performance and Costs of FFRB Vs. Standard Care in Suspected Coronary Artery Disease.
- Conditions
- Coronary Artery DiseaseCardiovascular DiseasesCardiovascular; StenosisCoronary OcclusionCoronary StenosisHeart DiseasesVascular DiseasesConstriction, PathologicPathological Conditions, Anatomical
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- National Heart Centre Singapore
- Target Recruit Count
- 340
- Registration Number
- NCT06681584
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
🇸🇬National Heart Centre Singapore, Singapore, Singapore
🇸🇬Tan Tock Seng Hospital, Singapore, Singapore
Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body
- Conditions
- Heart FailureCardiometabolic SyndromeCancer DiagnosisCardiovascular DiseasesHealthy Volunteers
- Interventions
- Drug: Hyperpolarized 13C-pyruvate
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- National Heart Centre Singapore
- Target Recruit Count
- 200
- Registration Number
- NCT06645691
- Locations
- 🇸🇬
National Heart Centre Singapore, Singapore, Singapore
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next
News
CADENCE and Medera Launch Asia's First Multi-Centre Gene Therapy Trial for Heart Failure in Singapore
CADENCE and Medera's Sardocor have initiated Asia's first multi-centre gene therapy clinical trial for heart failure, with Singapore being the only site selected outside the United States.